当前位置:首页 - 行情中心 - 国药股份(600511) - 财务分析 - 现金流量表

国药股份

(600511)

  

流通市值:182.60亿  总市值:248.99亿
流通股本:5.53亿   总股本:7.55亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金54,186,457,995.9137,684,594,495.4624,255,287,154.7311,138,550,295.14
收到的税费返还1,049,896.05908,303.13111,502.5476,104.31
收到其他与经营活动有关的现金289,149,874.92237,106,113.57202,605,339.73131,230,254.55
经营活动现金流入的平衡项目0000
经营活动现金流入小计54,476,657,766.8837,922,608,912.1624,458,003,99711,269,856,654
购买商品、接受劳务支付的现金48,496,799,804.8435,585,661,984.7623,087,312,495.6511,536,464,063.4
支付给职工以及为职工支付的现金847,889,302.22631,529,666.85439,133,537.82258,650,319.92
支付的各项税费1,451,180,070.34984,685,107.35648,580,456.76401,417,123.35
支付其他与经营活动有关的现金954,131,491.95711,510,327.48449,034,646.99217,742,492.17
经营活动现金流出的平衡项目0000
经营活动现金流出小计51,750,000,669.3537,913,387,086.4424,624,061,137.2212,414,273,998.84
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额2,726,657,097.539,221,825.72-166,057,140.22-1,144,417,344.84
二、投资活动产生的现金流量:
收回投资收到的现金7,878,681.737,625,926.527,625,926.52625,172.72
取得投资收益收到的现金7,773,419.325,885,306.15,885,306.15,216,888.38
处置固定资产、无形资产和其他长期资产收回的现金净额161,051.16152,008.295,3503,820
收到的其他与投资活动有关的现金-57,755.2257,755.21-
投资活动现金流入的平衡项目0000
投资活动现金流入小计15,813,152.2113,720,996.0413,664,337.835,845,881.1
购建固定资产、无形资产和其他长期资产支付的现金145,124,184.2797,751,267.6866,566,292.621,661,391.78
投资活动现金流出的平衡项目0000
投资活动现金流出小计145,124,184.2797,751,267.6866,566,292.621,661,391.78
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-129,311,032.06-84,030,271.64-52,901,954.77-15,815,510.68
三、筹资活动产生的现金流量:
取得借款收到的现金203,195,997.9230,750,770.27167,196,067.45100,000,000
收到其他与筹资活动有关的现金276,474,938.47304,469,178.251,846,224.28272,033,932.97
筹资活动现金流入平衡项目0000
筹资活动现金流入小计479,670,936.37535,219,948.52169,042,291.73372,033,932.97
偿还债务支付的现金250,000,000251,269,489.8201,269,489.8100,000,000
分配股利、利润或偿付利息支付的现金780,138,629.31726,618,188.67678,671,669.8954,208,915.42
其中:子公司支付给少数股东的股利、利润70,560,925.0939,200,764.7922,734,291.6822,734,291.68
支付其他与筹资活动有关的现金81,708,180.85519,200,519.91151,132,747.7556,040,685.91
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,111,846,810.161,497,088,198.381,031,073,907.44210,249,601.33
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-632,175,873.79-961,868,249.86-862,031,615.71161,784,331.64
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额1,965,170,191.68-1,036,676,695.78-1,080,990,710.7-998,448,523.88
加:期初现金及现金等价物余额8,833,147,851.498,833,147,851.498,833,147,851.498,833,147,851.49
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额10,798,318,043.177,796,471,155.717,752,157,140.797,834,699,327.61
补充资料:
净利润2,334,470,740.61-1,062,676,754.05-
资产减值准备-388,870.07-9,440,883.24-
固定资产和投资性房地产折旧75,031,026.88-37,049,818.07-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧74,799,009.6-37,049,818.07-
投资性房地产折旧232,017.28---
无形资产摊销38,286,751.8-19,112,224.7-
长期待摊费用摊销8,572,884.72-3,972,905.09-
递延收益摊销8,288,892---
处置固定资产、无形资产和其他长期资产的损失-83,443.4--460,355.57-
固定资产报废损失54,020.88-2,427.61-
公允价值变动损失-10,817,458.31--34,725,094.18-
财务费用31,570,183.83-27,954,043.73-
投资损失-358,951,819.35--197,452,278.72-
递延所得税-7,194,611.2-7,711,790.54-
其中:递延所得税资产减少-500,099.37-10,985,431.4-
递延所得税负债增加-6,694,511.83--3,273,640.86-
存货的减少-243,603,868.56--228,753,171.57-
经营性应收项目的减少-292,548,102.02--1,878,943,628.28-
经营性应付项目的增加1,048,141,217.07-923,390,490.38-
其他--19,141.08-
现金的期末余额10,798,318,043.17-7,752,157,140.79-
减:现金的期初余额8,833,147,851.49-8,833,147,851.49-
公告日期2024-03-212023-10-252023-08-242023-04-26
审计意见(境内)标准无保留意见
TOP↑